Beaufort CRO
Clay Gill serves as the President of Beaufort since May 2009, where leadership encompasses global operations, innovation, and client engagement within the contract research industry. Previously, Clay held the position of SVP, Chief Marketing & Business Development Officer, overseeing business development, marketing, and talent acquisition. Prior experience includes a significant tenure at Dominion Enterprises from 1993 to 2009, progressing through various roles, ultimately becoming SVP of Corporate Strategy & Business Development, and contributing to substantial company growth. Early career roles include Associate Brand Manager at Kraft Foods and Commercial Banking Officer at First Union National Bank. Clay Gill holds an MBA from the University of Virginia Darden School of Business and a BA in Religious Studies from Davidson College.
Beaufort CRO
Beaufort is a global CRO built around one purpose — helping life science companies improve and save lives through the rapid development and commercialization of innovative products. Our shared interest and commitment to your success drives our entire organization to deliver best-in-class clinical trial services, regulatory strategy and planning, data and business analytics, data management and statistics, and quality services. We are: ◈ MedTech Focused - Industry-leading expertise to streamline your clinical development. ◈ IVD Specialists - Two decades of extensive diagnostic experience. ◈ Results Oriented - Guided by efficient and adaptive clinical trial management. ◈ Partnership Driven - 94% of clients rate Beaufort higher than other CROs Our experience includes: ◈ 500+ Regulatory Submissions including 510(k)s, PMAs, IDEs and CE-Marks ◈ 4,000+ Clinical Study Sites Around the Globe ◈ 1,000+ Clinical Trials Across a Wide Variety of Indications and Testing Platforms ◈ 2,600+ Clinical Professionals in Over 50 Countries See how Beaufort CRO can accelerate your medical innovation -- and put our experience to work for you.